venBio Select Advisor »

Cytokinetics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2026-03-31 $220M 3.3M 65.91
2016-06-30 $4.8M 504k 9.49

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Krystal Biotech Common (KRYS)
Argenx Se Sponsored ADR (ARGX)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals Common (XENE)
Structure Therapeutics Sponsored Ads (GPCR)
Terns Pharmaceuticals Common (TERN)
Vera Therapeutics Common (VERA)
Revolution Medicines Common (RVMD)
Cytokinetics Common (CYTK)

View all positions for venBio Select Advisor

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
Vanguard Group
FMR
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
venBio Select Advisor
Geode Capital Management
Bank of America Corporation
Rtw Investments
Armistice Capital
Integral Health Asset Management
Goldman Sachs Group

View all funds holding Cytokinetics